Preeclampsia Ratio (sFlt-1/PlGF)

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

August 27, 2020

Study Completion Date

August 27, 2020

Conditions
Preeclampsia
Interventions
BIOLOGICAL

sFlt-1 / PlGF ratio

"* Ambulatory management if sFlt-1 / PlGF ratio is below 38~* usual management if sFlt-1/PlGF is between 38 and 85.~* If the ratio is \> 85, monitoring will be intensified and patient hospitalization will be continued"

Trial Locations (1)

75014

CHU Cochin, Maternité Port Royal, Paris

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03289611 - Preeclampsia Ratio (sFlt-1/PlGF) | Biotech Hunter | Biotech Hunter